Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Monday, 25 January 2021

Investor Ideas #Potcasts 522, #Cannabis News and #Stocks on the Move (TSX: $VLNS.TO) (CSE: $HOLL.C) (CSE: $HARV.C) (CSE: $CURA.C)

 



 

Investor Ideas #Potcasts 522, #Cannabis News and #Stocks on the Move (TSX: $VLNS.TO) (CSE: $HOLL.C) (CSE: $HARV.C) (CSE: $CURA.C)

 

Delta, Kelowna, BC, January 25, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/012521-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/01251VLNS-HOLL-HARV-CURA.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few public company announcements.

 

The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) announced that it has entered into a definitive agreement to acquire all of the issued and outstanding shares of LYF Food Technologies Inc. in a cash and share transaction for closing consideration of CDN$24.9 million, plus up to an additional CDN$17.5 million in consideration payable upon the business achieving certain earn-out EBITDA milestones. The LYF Acquisition is expected to be accretive to the Company's EBITDA and diluted EPS in 2021, and if all of the Milestones are met, the transaction represents an approximate ~4.2x multiple on the last milestone achieved. With the LYF Acquisition, The Valens Company not only strengthens its already wide-reaching production capabilities for the 2.0 and 3.0 markets, but also unlocks significant growth potential with the addition of a cutting-edge platform designed to capitalize on one of the fastest growing product segments in the cannabis industry.

 

LYF is a premier edibles manufacturer based in Kelowna, British Columbia with expertise in novel product creation, white label manufacturing and infusion technologies. Similar to Valens, LYF operates a product development and manufacturing platform focused on consumer-driven innovation, and product safety and consistency. LYF brings a proven team with significant experience producing high throughput food products, in addition to experience operating and working with major Canadian grocery chains, health and wellness retailers, and pharmacies. Just minutes away from Valens' headquarters, LYF's purpose-built manufacturing facility produces innovative edible products using the highest quality ingredients and cannabis extracts, offered in proprietary delivery methods.

 

Valens' access to low-cost active ingredients paired with LYF's industry-recognized product IP formulations of over 100 recipes strengthens its capabilities to produce higher-margin, new-to-market edible formats in a segment with limited product variability, and increased consumer demand. With the added infrastructure and expertise from the LYF Acquisition, The Valens Company significantly expands its edibles footprint and strategy to remain a best-in-class manufacturing platform for its partners, while also increasing its ability to capture market share in the rapidly growing product category. Similar to consumer trends in the US cannabis market, edible products are anticipated to represent over 10% of sales in the maturing Canadian cannabis market.

 

Tyler Robson, Chief Executive Officer and Chair of the Board of The Valens Company, said, "LYF has set the standard of what high quality edibles should be and has developed a diverse and flexible manufacturing platform to play a dominant role in the Canadian edibles market. LYF stood out for its product innovation and marketing teams, as well as its broad range of edible products which will introduce new formats to Canadian consumers that are typically only available in more mature markets. We look forward to further developing our product offering to reach more consumers with high-quality and unique cannabis edibles as this product segment continues to gain in popularity."

 

"Our team could not be more thrilled to join forces with The Valens Company and collectively fuel our shared passion for producing exceptional cannabis products with consumers top of mind," said Paolo Pero and Matthew Amado, Founders of LYF. "As a fellow Kelowna-based company, Valens' vision for global growth resonated with the team and ultimately led us to recognize the significant value in combining what we have each uniquely created to bring a new level of manufacturing excellence to Canada and beyond."

 

 

 

Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF), diversified cannabis branding company with products in over 98 dispensaries throughout Arizona, commended the state of Arizona for its efficient activation of adult-use cannabis sales. Legal sales of adult use cannabis in Arizona commenced mid-day on Friday January 22nd, 2021, several months ahead of industry expectations, and the fastest that any of the 15 states with recreational marijuana has gone from voter approval to actual sales.

 

The company's wholly owned subsidiary, Venom Extracts product suite is a category leader with over 4 million grams sold in 2020, accounting for up to 30 percent of category sales state-wide. Venom is positioned for continued growth in Arizona, it has a strong brand recognition and distribution network, its products are available at leading retailers including Harvest Health and Recreation (CSE: HARV) (OTCQX: HRVSF), Curaleaf (CSE: CURA) (OTCQX: CURLF), Bloom, MuV and Oasis Cannabis dispensaries among others.

Arizona voted to legalize adult use cannabis in November, "Marijuana Business Daily projects that the state's recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024".

 

"Medical-marijuana dispensaries that got approved to sell recreational marijuana on Friday include 13 of the 15 Harvest shops in the state, all eight Curaleaf shops, The Mint locations in Guadalupe and Mesa, three Territory Dispensary locations, and dozens of others in places across the state, including in Tucson, Yuma, Flagstaff, Cottonwood and Sedona. Arizona Department of Health Services spokesman Steve Elliott said Friday that the department had approved 86 applications. Some dispensaries in the state are still waiting to file their applications because they are not yet prepared to offer recreational sales, which are expected to bring substantially more traffic to their stores". As reported by AZ Central on January 22nd, 2021.

 

In 2020, sales of medical cannabis in Arizona grew by greater than 27%, as such Venom has been a catalyst for revenue growth of the Company. On March 26th, 2020 (see press release dated March 30th, 2020), Hollister Biosciences acquired Venom Extracts and since the closing, in the three quarters following, Venom contributed approximately CDN$38 million to the company's 2020 revenue.  In the entire year of 2020, Venom Extracts generated greater than CDN$ 40 million in revenue (and CDN$4.8 million in adjusted EBITDA), up from CDN$16.4 million in 2019 a 144% year over year increase, and ending the year with a record month of sales for December totaling approximately CDN$5.5 million. These unaudited numbers represent record sales for the company, and the expectation is that sales growth will continue in 2021.

 

In addition to continued revenue growth, the company plans to focus on core growth area's including; enhancing; unit margins, market penetration, loyalty and same-store sales.

Some additional highlights of the company include:

       Branded Products now on sale in over 370 cannabis dispensaries in Arizona and California

       4 owned brands, and 3 brand collaborations

       Over 4 million grams sold

       Over 96,000 lbs. of cannabis biomass converted into finished products in Arizona

       Total sales for 2020 increased 3233% from 2019 and are estimated to be approximately CDN $40 million

       December 2020 sales totaled greater than CDN$6 million

The Company looks forward to continuing execution of its business plan and growth targets in 2021, primarily focused on the exponential growth anticipated in and continued market penetration of branded products throughout California.

 

 Global Trac Solutions, Inc. (OTC: PSYC), a digital media leader within the emerging sector of medicinal psychedelics, announced that the Company has entered into a Joint Venture Partnership with Minerco, Inc. (OTC: MINE), a Jamaican-based company specializing in growing, research, production and distribution of psilocybin mushrooms and marketing worldwide.

 

The JV creates an opportunity for the companies to collaborate on the co-development and hosting of virtual conferences and forums focused on educating, informing, and showcasing the potential medicinal benefits of psilocybin mushrooms, including the psilocybin-based products MINE is developing. Additionally, the JV allows for PSYC to serve as one of the primary digital marketing partners for MINE as they move forward with their focus of bringing their products to market.

 

“We are extremely delighted to partner with MINE, a company that is deeply-rooted in the sector of psilocybin mushrooms,” said Global Trac Solutions, Inc. CEO, David Flores. “And we’re thrilled to be able to combine our collective resources to develop and produce virtual conferences and forums in the coming months that we believe will effectively highlight this exciting sector within the psychedelic industry.”

 

“To JV with PSYC will be a great opportunity for both companies,” said Julius Jenge, Minerco, Inc. CEO. “MINE will have the ability to do real case studies using our own product and PSYC will be able to track the research with their media platform. This initiative will allow us to host forums with both industry experts and patients who will give real examples of the benefits of Psilocybin and more specifically MINE products.”

 

The companies intend to be able to collectively develop and produce their first joint virtual conference/forum within the next two months and will release more information to the public related to specific dates and times as soon as it is available.

 

“As our industry continues to gain more exposure and develop more momentum behind it, I believe we will continue to see an increase, globally, for platforms, such as Psychedelic Spotlight, that provide access to a wealth of informational and educational resources focused on this paradigm shift in healing and treatment that psychedelics like psilocybin are creating,” Flores said. “As MINE continues its focus on developing quality psilocybin-based products, we here at PSYC look forward to leveraging our expanding media platform and network to contribute to their growth and success in the months to come.”

 

 

CannabizTeam, the world's largest cannabis-focused executive search and staffing firm, has launched a new service line for cannabis companies: CT Board Placement. CT Board Placement assists cannabis industry clients in identifying and recruiting candidates for Board of Director positions who have a diverse blend of skills and experience that match the strategic direction of each client.

 

"Appointing the right non-executive directors is a critically important decision for all cannabis companies in today's competitive marketplace," said Liesl Bernard, CEO of CannabizTeam. "Recruiting directors in the cannabis space is a more complex process due to the relative youth of the industry and the lingering legacy legal nuances. Our goal with CT Board Placement is to help our clients find a diverse blend of candidates with relevant experience, strong character and reputation, proven judgment and leadership skills that will set them up for future success."

 

Board of Director diversity reflects one of the core values of CT Board Placement, which is especially relevant as the cannabis industry has continued to lead corporate America in social equity and corporate social responsibility programs. CannabizTeam is committed to promoting fairness, justice and equity in the cannabis industry, and will work to fill Board of Director positions with individuals of all genders, religions and races.

 

CT Board Placement will also offer a Cannabis Director Development Program to help first-time directors learn the culture and nuances of the company they will serve as well as the broader cannabis industry. The Cannabis Director Development Program includes a detailed curriculum exploring the most relevant governance issues in North America, with a special focus on issues facing boards in the U.S., Canadian and Mexican cannabis markets.

 

CT Board Placement is a division of CannabizTeam Worldwide, which also operates CT Executive Search, CannabizTeam Direct Hire and CannabizTemp. Through its four staffing divisions, CannabizTeam fills more than 1,000 cannabis positions each year in all verticals of the industry across the globe. CannabizTeam's proprietary database includes more than 100,000 successful executives with experience in and beyond the cannabis industry – an excellent resource for cannabis companies searching to fill Board of Director positions.

 

To learn more about CT Board Placement, visit: https://cannabizteam.com/cannabis-board-of-directors-recruitment/.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

#CBD #Stock Link Reservations Inc/LinkResPet (OTC: $LRSV) Expands CBD products from #pets to people; @res_pet

 

#CBD #Stock Link Reservations Inc/LinkResPet (OTC: $LRSV) Expands CBD products from #pets to people; @res_pet    

 

London, UK, January 25, 2021– Investorideas.com Newswire Breaking CBD stock news -Link Reservations Inc. (OTC: LRSV), a provider of cannabidiol (CBD) products specifically tailored for pets, announces it has purchased DailyLifeCBD – a website selling CBD products for people. As part of this, the Company has acquired both the DailyLifeCBD IP, website domain and existing product line. By LRSV expanding into selling CBD products for people its positioned for substantial potential revenue growth. Our focus is to continue focusing on acquistions , expanding products, growing revenue & increasing shareholder value

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/cannabis/01251LRSV-CBD-Pets-People.asp


LRSV targeted DailyLifeCBD in a bid to expand its presence in the CBD market and purchased the website & existing product line. The purchase means Link Reservations can expand its operations with a sister site to LinkResPet, which will be focused on products for the human market.

 

“This is an exciting opportunity for LRSV as we move to expand into the highly popular and lucrative CBD wellness sector”, commented Rene Lauritsen, CEO at LinkResPet. “By having a base for CBD wellness products, we will be able to grow our target audience organically to start with, by offering our existing pet owner customers products for both their pets and soon themselves, through a whole new range tailored for personal use. At the same time, the possibility to grow our market presence and customer base beyond that is very significant, as people don’t need to have a pet to be interested in our CBD products”, he explained.

 

According to a Nielsen study, approximately 74% of consumers who purchase CBD products own pets, and 24% of pet owners use hemp or CBD for themselves, their pet or both. In fact, about 26% of dog owners are using CBD products, of which half are already administering it to their dogs.

 

The Company plans to initiate activities through DailyLifeCBD with a range of non-edible lifestyle products and expand on the range as the site and demand grows.

 

For more information about DailyLifeCBD please visit: https://dailylifecbd.com/

 

For more information about LinkResPet, please visit www.linkrespet.com or follow them on Twitter on @ HYPERLINK "https://twitter.com/res_pet"res_pet

 

About Link Reservations Inc.

Link Reservations Inc is CBD Petcare provider dedicated to improving the health and life conditions of pets worldwide. Developing and marketing hemp-based CBD products for cats, dogs and horses, the Company is currently present in Europe and in the US. A pioneer in the area, Link Reservations Inc products can be found under its brand LinkResPets (www.linkrespet.com). 

 

Forward-Looking Statements & Disclaimers:
The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

 

Linkreservations Inc

400 Thames Valley Park Drive

Reading Berkshire RG6 1 PT

United Kingdom

Phone: +44 330 808 0897

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring Link Reservations is a paid for service on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

Friday, 22 January 2021

Investor Ideas #Potcasts 521, #Cannabis News and #Stocks on the Move; (TSX: $ACB.TO) (NYSE: $ACB) (CSE: $MCUR.C) (OTCQB: $MCURF) (NYSE: $HEXO) (TSX: $HEXO.TO)

 



 

Investor Ideas #Potcasts 521, #Cannabis News and #Stocks on the Move; (TSX: $ACB.TO) (NYSE: $ACB) (CSE: $MCUR.C) (OTCQB: $MCURF) (NYSE: $HEXO) (TSX: $HEXO.TO)

 

Delta, Kelowna, BC, January 22, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/012221-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/01221ACB-MCUR-HEXO.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few public company announcements.

 

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) announced that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company, at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million. Each Unit will be comprised of one common share of the Company and one half of one common share purchase warrant of the Company. Each Warrant will be exercisable to acquire one common share of the Company for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

 

The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 10% of the Offering to cover over-allotments, if any. This option may be exercised by the Underwriters for additional Units, Common Shares, Warrants or any combination of such securities. 

 

The net proceeds of the offering will be used for general corporate purposes, which may include opportunistically reducing debt. The Company believes that the Offering fits with its broader strategy to have a strong balance sheet while maintaining maximum flexibility to invest and build towards being a leader in global cannabinoids.

 

The closing of the Offering is expected to take place on or about January 26, 2021 and will be subject to customary conditions, including approvals of the Toronto Stock Exchange and the New York Stock Exchange.

 

A prospectus supplement to the Company’s short form base shelf prospectus dated October 28, 2020 will be filed with the securities commissions or securities regulatory authorities in each of the provinces of Canada, except Quebec, and with the U.S. Securities and Exchange Commission (the “SEC”) as part of the Company’s registration statement on Form F-10 (the “Registration Statement”) under the U.S./Canada Multijurisdictional Disclosure System. The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the proposed Offering. Prospective investors should read the Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement and the other documents the Company has filed for more complete information about the Company and this Offering before making an investment decision.

 

Copies of the Prospectus Supplement, following filing thereof, and the Base Shelf Prospectus will be available on SEDAR at www.sedar.com and copies of the Prospectus Supplement and the Registration Statement will be available on EDGAR at www.sec.gov. Copies of the Prospectus Supplement, following filing thereof, the Base Shelf Prospectus and the Registration Statement may also be obtained from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 or by telephone at (905) 791-3151 Ext 431 or by email at torbramwarehouse@datagroup.ca or from BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036 (Attn: Equity Syndicate), or by telephone at (800) 414-3627 or by email at bmoprospectus@bmo.com. Copies of such documents may also be obtained from ATB Capital Markets Inc., Attn: Gail O'Connor, 410-585 8th Ave SW, Calgary, Alberta, T2P 1G1, (403) 539-8629 or by email from atbcm_dealflow@atb.com.

 

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) announced its inclusion among 17 psychedelic companies in the first ever Psychedelic ETF. Horizon's Psychedelic ETF, is expected to commence trading Jan. 26, 2021 under ticker PSYK on the NEO exchange.

 

The ETF includes companies in the Canadian legal psychedelics industry, as well as U.S. companies engaged in legal activities involving psychedelic drugs and substances. The purpose of the ETF is to "invest in, and indirectly derive revenues from, companies in the psychedelics industry engaged in legal activities involving psychedelic drugs and substances."

 

"We are honoured to be selected as part of the first ever Psychedelic ETF. This is a milestone moment for our industry and for MINDCURE, as we continue to explore, develop and commercialize products to give hope and healing to a world in pain and suffering from a mental health crisis. This solidifies our position amongst peers and gives investors a great opportunity to support our industry as a whole," said Kelsey Ramsden, President & CEO, MINDCURE. "We congratulate our peers and believe it is a privilege to build a new category of care and investment together."

 

Lastly we look at Canadian cannabis product recalls over the month of January. While many investors focus heavily on company financials as well as company news, focussing on product recalls has been a more underrated segment of cannabis business considerations.

 

On January 12th, 2021, Hexo Corp. (NYSE: HEXO) (TSX:HEXO) had a product recall, announced by the Ontario Cannabis Store (OCS) online retailer, which impacted three types of disposable vape pens.

Hexo told Marijuana Business Daily the vapes were sold in Alberta, Manitoba, New Brunswick, Ontario and Saskatchewan as well as to medical cannabis clients.

 

The producer attributed the recall to “a mechanical hardware defect, in which prolonged auto-ignition may lead to excess heat in the battery cell, which in turn may cause melting of the plastic shell.”

 

“As an immediate corrective action, Hexo has implemented enhanced third-party hardware approval criteria including the use of an independent third-party accredited lab to assess all devices under consideration,” Shannon McCoy, Hexo vice president of quality, wrote in a statement emailed to MJBizDaily.

 

“Hexo expects the financial impact of the voluntary recall to be minimal, and well within the normal course of business,” McCoy added, without specifying the exact number of recalled vape pens.

 

On January 7th, 2021, The Agro-Greens had a recall issued by Health Canada which affected 752 units of North 40 Black Cherry Punch cannabis bud sold to medical cannabis clients via mail and by recreational cannabis retailers in Saskatchewan.

 

“The affected product may contain mold,” Health Canada said in its recall notice, adding that Agro-Greens had received four complaints about the lot and one report of an adverse reaction.

 

Now this cannabis product was flagged by one Grower North 40 Cannabis, who flagged the mold issue to the public in a Dec. 27 tweet, “All environmental conditions were on point throughout the drying and curing,” North 40 noted in its tweet. “It looks like a very isolated incident.”

 

The moldy bud was also identified in a late December post on a Reddit message board, said David Purcell, chief revenue officer at Shelter Cannabis, which is in the process of acquiring Agro-Greens.

 

Another recall issued on January 8th, 2021 involved 600 units of cannabis bud with erroneous THC and CBD values. The 3.5-gram packages of Oceanic Sea Breeze Cannabis, grown by Delta 9 Bio-Tech of Manitoba and sold at stores in Newfoundland and Labrador, had “incorrect cannabinoid values, where the labelled total THC and total CBD are higher than the actual values,” said Health Canada’s recall notice.

Inaccurate cannabinoid labeling has caused the majority of cannabis recalls in Canada since recreational legalization in 2018.

 

In the past year, labeling-related recalls have affected products such as flower from Aurora Cannabis subsidiary MedReleaf, pre-rolls from Sundial Growers, beverages from AgMedica Bioscience and ingestible cannabis oil from Voyage Cannabis.

 

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Psychedelic Stock News: Red Light Holland (CSE: TRIP) Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements

Psychedelic Stock News: Red Light Holland (CSE: TRIP) Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements